Aehr Test Systems, Inc. (AEHR)
NASDAQ: AEHR · Real-Time Price · USD
25.15
-0.04 (-0.16%)
Sep 9, 2025, 1:01 PM - Market open

Aehr Test Systems Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Aehr Test Systems.

Price Target: $ (0.00%)
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Aehr Test Systems.

Recommendation Trends

RatingDec '23Jan '24Feb '24Mar '24
Strong Buy0000
Buy1110
Hold0000
Sell0000
Strong Sell0000
Total1110

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Craig-Hallum
Craig-Hallum
Hold
Downgrades
$12
HoldDowngrades$12-52.29%Mar 26, 2024
William Blair
William Blair
Hold
Downgrades
n/a
HoldDowngradesn/an/aMar 25, 2024
William Blair
William Blair
Buy
Initiates
n/a
BuyInitiatesn/an/aOct 17, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
62.59M
from 58.97M
Increased by 6.13%
Revenue Next Year
83.56M
from 62.59M
Increased by 33.51%
EPS This Year
0.08
from -0.13
EPS Next Year
0.31
from 0.08
Increased by 281.25%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMay 31, 2021May 31, 2022May 31, 2023May 31, 2024May 30, 2025May 30, 2026May 30, 2027
Revenue
16.60M50.83M64.96M66.22M58.97M62.59M83.56M
Revenue Growth
-25.53%206.20%27.80%1.94%-10.95%6.13%33.51%
EPS
-0.090.340.501.12-0.130.080.31
EPS Growth
--47.06%124.00%--281.25%
Forward PE
-----308.2180.84
No. Analysts
-----55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202620272028
High67.7M93.6M
Avg62.6M83.6M
Low54.6M73.3M

Revenue Growth

Revenue Growth202620272028
High
14.8%
49.5%
Avg
6.1%
33.5%
Low
-7.4%
17.2%

EPS Forecast

EPS202620272028
High0.110.48
Avg0.080.31
Low0.060.15

EPS Growth

EPS Growth202620272028
High-
491.9%
Avg-
281.2%
Low-
80.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.